Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Clinical trial NCT00453310 · COMPLETED

Trial details

NCT number: NCT00453310
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor

Start date: 2007-03-01
Primary completion: 2008-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.